Agouron Pharmaceuticals (AGPH) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Agouron Pharmaceuticals (AGPH)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Steve Fancy who wrote (3570)	1/9/1998 3:40:00 PM
From: margie	Read Replies (2) of 6136

Earnings will be released on Monday, January 12. according to Agouron IR. Here are some recent upwards revisions, from Zacks. AGPH: BANCAM/ROB STEP increased estimate for fiscal year ending 06/98 from $0.72 to $0.83 on 01/08/98 AGPH: BANCAM/ROB STEP increased estimate for fiscal year ending 06/99 from $1.15 to $1.18 on 01/08/98 AGPH: BANCAM/ROB STEP increased estimate for quarter ending 03/98 from $0.29 to $0.33 on 01/08/98 AGPH: NATNBK MONT.SEC has reiterated estimate for fiscal year ending 06/98 of $0.87 on 01/08/98 AGPH: NATNBK MONT.SEC has reiterated estimate for quarter ending 12/97 of $0.15 on 01/08/98 The Zacks consensus estimate of earnings per share for AGPH's 12/97 quarter is $0.14.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next